Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

Quetiapine Fumarate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

136 API Suppliers, 58 USDMF, 44 CEP/COS, 10 JDMF, 31 EU WC, 34 KDMF, 31 NDC API, 77 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

61 Drugs in Development

61 Drugs in Development

INTERMEDIATES

37 Intermediate Suppliers

37 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1550 FDF Dossiers, 203 FDA Orange Book, 909 Europe, 121 Canada, 69 Australia, 113 South Africa, 135 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 100MG BASE, TABLET;ORAL - EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 200MG BASE, TABLET;ORAL - EQ 25MG BASE, TABLET;ORAL - EQ 300MG BASE, TABLET;ORAL - EQ 400MG BASE, TABLET;ORAL - EQ 50MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 150MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 200MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 300MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 400MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 50MG BASE

RELATED EXCIPIENT COMPANIES

4 SPI Pharma, 6 DKSH, 11 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 3 Kirsch Pharma, 1 ACG Worldwide, 9 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 1 Avesta Pharma, 26 BASF, 2 Clariant, 11 Corel Pharma Chem, 7 DFE Pharma, 1 Esteem Industries, 2 Finar, 13 Gangwal Chemicals, 5 Ideal Cures, 4 Ingredion Pharma Solutions, 26 Kerry, 3 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 4 Pharmatrans-Sanaq, 5 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 18 Roquette, 14 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 11 Sigachi Industries, 4 Silverline Chemicals, 3 The Dow Chemical Company, 3 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

62 Fillers, Diluents & Binders, 48 Coating Systems & Additives, 40 Disintegrants & Superdisintegrants, 35 Direct Compression, 32 Granulation, 30 Solubilizers, 29 Controlled & Modified Release, 28 Thickeners and Stabilizers, 19 Parenteral, 18 Topical, 17 Film Formers & Plasticizers, 15 Lubricants & Glidants, 14 Co-Processed Excipients, 11 Chewable & Orodispersible Aids, 10 Emulsifying Agents, 9 Taste Masking, 7 API Stability Enhancers, 7 Rheology Modifiers, 5 Surfactant & Foaming Agents, 5 Coloring Agents, 5 Empty Capsules, 4 Vegetarian Capsules

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 60 News #PharmaBuzz

GLOBAL SALES INFORMATION

31 US Medicaid Prescriptions, 255 Regulatory FDF Prices, 13 Annual Reports

MARKET PLACE

13 APIs, 10 FDF Dossiers

PATENTS & EXCLUSIVITIES

5 Health Canada Patents

5 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 4 USP, 5 JP, 41 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
29/11/2025	Cohance Lifesciences	India	COHANCE LIFESCIENCES LIMITED Mumbai IN	CEP 2017-175 - Rev 02	Quetiapine Fumarate	2025-07-22	Valid	Chemical		2541
29/11/2025	Fermion Oy	Finland	FERMION OY Espoo FI	CEP 2015-170 - Rev 01	Quetiapine Fumarate	2023-10-16	Valid	Chemical		2541

Quetiapine Fumarate

Quetiapine Fumarate

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

136 API Suppliers

58 USDMF

44 CEP/COS

10 JDMF

31 EU WC

34 KDMF

31 NDC API

77 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

61 Drugs in Development

INTERMEDIATES

37 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1550 FDF Dossiers

203 FDA Orange Book

909 Europe

121 Canada

69 Australia

113 South Africa

135 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 100MG BASE

TABLET;ORAL - EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 200MG BASE

TABLET;ORAL - EQ 25MG BASE

TABLET;ORAL - EQ 300MG BASE

TABLET;ORAL - EQ 400MG BASE

TABLET;ORAL - EQ 50MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 150MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 200MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 300MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 400MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 50MG BASE

RELATED EXCIPIENT COMPANIES

4 SPI Pharma

6 DKSH

11 Boai NKY Pharmaceuticals Ltd

5 Gangwal Healthcare

6 Nanjing Well Pharmaceutical

3 Kirsch Pharma

1 ACG Worldwide

9 Actylis

1 Aeon Procare

1 Alcedo Pharmachem

9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

1 Avesta Pharma

26 BASF

2 Clariant

11 Corel Pharma Chem

7 DFE Pharma

1 Esteem Industries

2 Finar

13 Gangwal Chemicals

5 Ideal Cures

4 Ingredion Pharma Solutions

26 Kerry

3 Keval Exports

4 Kima Chemical

6 Lonza Capsugel

13 Microlex e.U

1 Nanjing Bold Chemical

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

4 Novo Excipients

4 Pharmatrans-Sanaq

5 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

18 Roquette

14 Seppic

TABLET;ORAL - EQ 150MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons